News – Page 12 – Asian Fund for Cancer Research

Personal Discipline and Perseverance Are Still the Best Practice to Prevent COVID-19 in 2020 Amid the Uncertainty of Protective Vaccine Availability

06/19/2020AFCR News, Coronavirus

Michael Wang, MD., Ph.D., member of AFCR Scientific Advisory Board Excitement spread quickly after a June 14 report that a COVID-19 vaccine developed by Imperial College London in the U.K. will be tested in humans. What excites people is that the vaccine, which…

Will This Drug Relight the Dimming Hope of Finding Effective Therapies for COVID-19?

06/06/2020AFCR News, Coronavirus

Michael Wang, MD., Ph.D., member of AFCR Scientific Advisory Board Many people were disappointed by recent high-profile clinical trial results on Remdesivir, the drug that people had put high hopes on as the best candidate for an effective COVID-19 treatment. A report published in…

Can Vaccines Win the Race Against the Novel Coronavirus?

06/01/2020AFCR News, Coronavirus

Michael Wang, MD., Ph.D., member of AFCR Scientific Advisory Board The U.S. death toll has passed the 100,000 mark this week, but effective anti-viral drugs are still not available for the treatment of COVID-19. Rather, many people have been putting their hope on…

Don’t Ignore These Ovarian Cancer Related Symptoms

05/26/2020AFCR News, Awareness, Cancer Types & Facts

Often known as “the silent killer”, ovarian cancer is difficult to detect early because the ovaries are deep within the pelvis and initial symptoms are often ambiguous and non-specific. Too often the cancer goes undiagnosed until after the disease is far advanced…

Better Treatment Is on the Way as Doctors Know More about the Tricks of Novel Coronavirus

05/22/2020AFCR News, Coronavirus

Michael Wang, MD., Ph.D., member of AFCR Scientific Advisory Board On February 11, weeks into the COVID-19 outbreak, the novel coronavirus was officially called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as most patients showed mild to severe respiratory illness. Doctors shared the…

AACR Virtual Annual Meeting I presents new data on cancer biology, treatment, screening, risk reduction

05/16/2020Global Cancer News

Brief points covered in the America Association for Cancer Research (AACR) Virtual Annual Meeting I held on April 27-28th: -Treating BRAF-Positive Melanoma by adding checkpoint inhibitor Tecentriq (atezolizumab) to a combination of two targeted drugs Zelboraf (vemurafenib) and Cotellic (cobimetinib) -PARP Inhibitor (targeted drugs…

Link between Children with Cancer and COVID-19

05/16/2020Global Cancer News

May 16th, 2020 A study indicates that children with cancer are not at increased risks of severe cases of COVID-19, and researchers find that Medicaid expansion was associated with reduced cancer deaths. Read more at: https://www.cancertodaymag.org/Pages/cancer-talk/May-15-The-Week-in-Cancer-News.aspx

FDA Approves Pemazyre (Pemigatinib) for Bile Duct Cancer

05/16/2020Global Cancer News

The US Food and Drug Administration (FDA) approved the first targeted therapy for bile duct cancer. Pemazyre (pemigatinib) is for adults with advanced bile duct cancer whose cancer has grown after at least one previous chemotherapy treatment and whose tumors have a mutation in the FGFR2 gene. Full…

FDA Approves Trodelvy (Sacituzumab govitecan-hziy) for Triple Negative Breast Cancer

05/16/2020Global Cancer News

The US Food and Drug Administration (FDA) approved a new type of therapy for triple-negative breast cancer that has spread to other parts of the body and hasn’t responded to other treatments. Triple-negative breast cancer is called that because the cancer cells…

Common Questions About the New Coronavirus Outbreak

05/16/2020Global Cancer News

Cancer patients are among those at high-risk of serious illness from an infection because their immune systems are often weakened by cancer and its treatments. Although most people who were treated for cancer in the past (especially if it was years ago)…